Signadori Bio Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $13M

  • Investors
  • 3

Signadori Bio General Information

Description

Developer of an in vivo monocyte immunotherapy platform designed to treat solid tumors by engineering immune cells to target cancer. The company's platform offers an off-the-shelf approach using gene-modified monocytes to harness immune activity and address the challenges of the tumor microenvironment, enabling the treatment of patients with solid tumors with an approach designed to improve immune responses within tumors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 7-11 Boulevard Haussmann
  • Paris
  • France
Primary Industry
Biotechnology
Corporate Office
  • 7-11 Boulevard Haussmann
  • Paris
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Signadori Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 05-May-2026 $13M Completed Pre-Clinical Trials
To view Signadori Bio’s complete valuation and funding history, request access »

Signadori Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Signadori Bio Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Invivo Partners Venture Capital Minority
Sofinnova Partners Venture Capital Minority
Taiho Ventures Corporate Venture Capital Minority
To view Signadori Bio’s complete investors history, request access »

Signadori Bio FAQs

  • When was Signadori Bio founded?

    Signadori Bio was founded in 2025.

  • Where is Signadori Bio headquartered?

    Signadori Bio is headquartered in Paris, France.

  • What is the size of Signadori Bio?

    Signadori Bio has 8 total employees.

  • What industry is Signadori Bio in?

    Signadori Bio’s primary industry is Biotechnology.

  • Is Signadori Bio a private or public company?

    Signadori Bio is a Private company.

  • What is Signadori Bio’s current revenue?

    The current revenue for Signadori Bio is .

  • How much funding has Signadori Bio raised over time?

    Signadori Bio has raised $13M.

  • Who are Signadori Bio’s investors?

    Invivo Partners, Sofinnova Partners, and Taiho Ventures have invested in Signadori Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process